全文获取类型
收费全文 | 20295篇 |
免费 | 999篇 |
国内免费 | 109篇 |
专业分类
耳鼻咽喉 | 199篇 |
儿科学 | 289篇 |
妇产科学 | 161篇 |
基础医学 | 2554篇 |
口腔科学 | 338篇 |
临床医学 | 1266篇 |
内科学 | 5088篇 |
皮肤病学 | 398篇 |
神经病学 | 1444篇 |
特种医学 | 820篇 |
外科学 | 3787篇 |
综合类 | 75篇 |
一般理论 | 1篇 |
预防医学 | 677篇 |
眼科学 | 427篇 |
药学 | 1527篇 |
中国医学 | 58篇 |
肿瘤学 | 2294篇 |
出版年
2023年 | 98篇 |
2022年 | 244篇 |
2021年 | 424篇 |
2020年 | 221篇 |
2019年 | 314篇 |
2018年 | 373篇 |
2017年 | 316篇 |
2016年 | 415篇 |
2015年 | 429篇 |
2014年 | 527篇 |
2013年 | 697篇 |
2012年 | 1004篇 |
2011年 | 1159篇 |
2010年 | 658篇 |
2009年 | 572篇 |
2008年 | 963篇 |
2007年 | 1096篇 |
2006年 | 1079篇 |
2005年 | 1081篇 |
2004年 | 1117篇 |
2003年 | 1070篇 |
2002年 | 1080篇 |
2001年 | 506篇 |
2000年 | 507篇 |
1999年 | 500篇 |
1998年 | 250篇 |
1997年 | 219篇 |
1996年 | 190篇 |
1995年 | 152篇 |
1994年 | 154篇 |
1993年 | 164篇 |
1992年 | 397篇 |
1991年 | 351篇 |
1990年 | 341篇 |
1989年 | 320篇 |
1988年 | 300篇 |
1987年 | 308篇 |
1986年 | 286篇 |
1985年 | 223篇 |
1984年 | 158篇 |
1983年 | 156篇 |
1982年 | 56篇 |
1981年 | 63篇 |
1979年 | 117篇 |
1978年 | 60篇 |
1977年 | 62篇 |
1974年 | 57篇 |
1973年 | 60篇 |
1972年 | 67篇 |
1970年 | 50篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
Peroxisome proliferator-activated receptor delta (PPARdelta), a novel target site for drug discovery in metabolic syndrome. 总被引:5,自引:0,他引:5
Sadao Takahashi Toshiya Tanaka Tatsuhiko Kodama Juro Sakai 《Pharmacological research》2006,53(6):501-507
The development of new treatments for metabolic syndrome is urgent project for decreasing the prevalence of coronary heart disease and diabetes mellitus in the advanced countries. Peroxisome proliferator-activated receptor (PPAR)alpha and gamma agonists have shed light on the treatment of hypertriglyceridemia and type 2 diabetes mellitus, respectively. Among PPARs, analysis of the PPARdelta functions is lagging behind because specific PPARdelta agonists have not been developed. The appearance of new PPARdelta agonists is brightening the prospects for elucidating the physiological role of PPARdelta. PPARdelta is a new target for the treatment of metabolic syndrome. In particular, the fact that fatty acid oxidation and energy dissipation in skeletal muscle and adipose tissue by PPARdelta agonists lead to improved lipid profile, reduced adiposity and insulin sensitivity is a breakthrough. It seems that treatment of PPARdelta agonists operate similarly to the caloric restriction and prolonged exercise. We suggest that the physiological role of PPARdelta may be an indicator for switching from glucose metabolism to fatty acid metabolism. To receive new benefits of PPARdelta agonists against metabolic syndrome by increasing fatty acid consumption in skeletal muscle and adipose tissue, we need to unveil more details on the functions of PPARdelta itself and its agonists in the future. 相似文献
4.
Eijiro Morita Torao Tanaka Tetsuya Nakamura Fumitaka Terabe Ichiro Hirata Kenichi Katsu Masakazu Takazoe Akira Terano 《Digestive endoscopy》2006,18(4):263-268
Background and Aims: Video capsule endoscopy (VCE) has become increasingly important as a simple method for observing the entire small intestine. The indications for VCE are obscure gastrointestinal bleeding and investigation of Crohn’s disease (CD). However, the correlation between endoscopic findings obtained by VCE and clinical findings in known cases of CD is not clear, and we therefore investigated this in the present study. Patients and methods: In 30 patients with known CD (Crohn’s disease activity index [CDAI] 0–420; median = 158.3), double contrast enteroclysis (ENT) was performed 1–3 weeks prior to VCE. The relationship between the VCE findings and hematological analysis/CDAI was examined. Results: In 17 of 30 patients, the entire small intestine could be investigated by VCE, whereas in the remaining 13 patients the terminal ileum could not be investigated. The following exhibited positive correlations: total lesions and CDAI (correlation coefficient values: rs = 0.661, adjusted P < 0.0061), ulcers and C‐reactive protein (CRP) (rs = 0.607, adjusted P < 0.0061), total lesions and CRP (rs = 0.604, adjusted P < 0.0061). Conclusions: Analysis with VCE suggests that CDAI and CRP indicate the activity of intestinal lesions in patients with known CD, and that CRP, in particular, is associated with the activity of ulcerative lesions of the intestine. This may contribute to revised guidelines for VCE in the future. 相似文献
5.
6.
7.
Y Tomino H Sakai M Miura T Suga M Yagame M Endoh Y Nomoto 《American journal of nephrology》1986,6(3):187-192
A study of double immunofluorescence-staining of immunoglobulins and sialic acids in the glomeruli from patients with IgA nephropathy is described. Renal biopsy specimens from patients with IgA nephropathy were stained with rhodamine-labeled antihuman IgA, IgG or IgM antisera and then stained with FITC-labeled Limulus polyphemus (LPA), Tricum vulgaris (WGA) or antihuman C3 antisera. Marked positive stainings of IgA and C3 and positive binding of LPA or WGA were observed in the glomerular mesangial areas from patients with IgA nephropathy. LPA or WGA were not bound with glomerular capillary walls from patients with moderate and advanced stages of IgA nephropathy, although depositions of IgA and C3 were markedly observed in such walls. There was a significant inverse correlation between the deposition of IgA and the binding of LPA or WGA in glomerular capillary walls obtained from these patients with IgA nephropathy. The levels of proteinuria from patients with moderate and advanced stages of IgA nephropathy were significantly higher than those with minimal and slight stages of such disease. It is suggested that the decrease of sialic acids in glomerular capillary walls might be due to a deposition of IgA in some patients with IgA nephropathy. It is concluded that high levels of proteinuria might be due to the decrease of sialic acids in glomerular capillary walls from patients with moderate and advanced stages of IgA nephropathy. 相似文献
8.
9.
H Nakagawa M Kikuhara M Sato K Sakai S Kimura 《Gan to kagaku ryoho. Cancer & chemotherapy》1987,14(9):2767-2770
A 50-year-old woman with bilateral inflammatory breast cancer (T4, N1b, M1, Stage IV) underwent right extended radical mastectomy and left modified radical mastectomy following pre-operative administration of carcinostatics (ADM, 5-FU) and irradiation. However, tumor recurrence was observed at the skin and right pleural cavity after the operation. Adriamycin-containing combination chemotherapy and radiation therapy were performed, but no significant response was obtained. CDDP was then administered intravenously at a daily dose of 62.5 mg/m2 at intervals of 60 days. The pleural effusion disappeared and the extent of skin metastasis was reduced, resulting in partial response which lasted for 90 days. The serum CEA level decreased from 13.1 ng/ml to 2.3 ng/ml. As the side effects of this therapy, slight nausea, vomiting and general fatigue were observed. This result suggested that CDDP is an effective drug for inflammatory breast cancer. 相似文献
10.